Homepage

COVID-19 vaccine development

A vaccine candidate for COVID-19 has been identified by researchers from the Oxford Vaccine Group and Oxford's Jenner Institute.

Professor Pollard among the world's most distinguished paediatricians

Congratulations to Professor Andrew Pollard, named as one of three 2019 Rosén von Rosenstein laureates.

Is mandatory vaccination the best way to tackle falling rates of childhood immunisation?

Following the publication of figures showing UK childhood vaccination rates have fallen for the fifth year in a row, researchers from OVG and the Oxford Martin Programme on Collective Responsibility for Infectious Disease discuss possible responses.

Ebola vaccine approved as second jab trialled

It’s very exciting to see that the Ad26.ZEBOV/MVA-BN-Filo Ebola vaccine schedule is being used in a large-scale study in the Democratic Republic of Congo. This is an important step towards having multiple vaccine strategies available to fight this dreadful illness, as is the recent application for marketing authorisation of this schedule by the European Medicines Agency.

Typhoid vaccine over 81% effective in tackling disease in Nepal

A large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting.

Dr Vanderslott and Dr Kirchelle stand at the exhibition with the Typhoidland poster in the background

Alice in Typhoidland: Join Lewis Carroll’s Alice on a journey through the story of typhoid, from Victorian sewer systems to cutting-edge scientific research

A new exhibition tells the story of Oxford’s role in the fight against typhoid, from pioneering efforts to eliminate typhoid in the era of Lewis Carroll’s Alice in Wonderland to game-changing present-day vaccine trials.

Take part in a clinical trial – see a list of all the trials we are currently recruiting to.

Vaccine Knowledge

The Vaccine Knowledge Project aims to be a source of independent information about vaccines and infectious diseases.

See more

Research

Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.

Explore

Events and Training

We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.

Learn

Get involved

There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.

Participate

Upcoming events

CANCELLED Hot Topics In Infection And Immunity In Children - IIC 2020

Monday, 29 June 2020 to Wednesday, 01 July 2020 @ St Catherine's College, Manor Road, Oxford, OX1 3UJ

**This event has been cancelled. We hope to go ahead with the 2020 programme for IIC 2021, scheduled for 1 - 3 July 2021** IIC - The ESPID-Oxford Course is a residential training course covering topics in paediatric infection for paediatric infectious diseases trainees and trainers, and for all those who manage children with infections. This will be the 18th edition of the course.

Latest publications

Rational use of face masks in the COVID-19 pandemic
Journal article

Feng S. et al, (2020), The Lancet Respiratory Medicine
A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa.
Journal article

Lo SW. et al, (2020), J Antimicrob Chemother, 75, 512 - 520
The science of vaccine safety: Summary of meeting at Wellcome Trust.
Journal article

Plotkin SA. et al, (2020), Vaccine
Interventions for increasing the uptake of immunisation in healthcare workers
Journal article

Tuckerman J. et al, (2020), Cochrane Database of Systematic Reviews, 2020
A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease
Journal article

Shields AM. et al, (2020), Journal of Clinical Immunology

How does herd immunity work?

‘Herd immunity’ or 'herd protection' gives protection to vulnerable people such as newborn babies, elderly people and those who are too sick to be vaccinated.

Value of Vaccines campaign

We recently worked with Mediaplanet on the 2019 Health Awareness: Value of Vaccines campaign. The campaign features exclusive content from key thought leaders and industry voices about the critical importance of full immunisation throughout life.

Take a look!